DeepMed Research

MEDICAL COLLEGE OF WISCONSIN

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1893-01-01

Employees: 5K

Market Cap: -

Website: http://www.mcw.edu

Clinical Trials

Treating Central Neuropathic Pain With Low Dose Naltrexone for People With Spinal Cord Injury

Phase 2

Recruiting

Conditions: Central Neuropathic Pain
Spinal Cord Injury

Interventions: Drug: 4.5mg daily dose of naltrexone

First Posted Date: 2024-12-09

Last Posted Date: 2025-05-14

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 10

Registration Number: NCT06723561

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Oral Fosamprenavir + Sodium Alginate for GERD

Phase 2

Not yet recruiting

Conditions: Refractory Gastroesophageal Reflux Disease
Gastroesophageal Reflux Disease

Interventions: Drug: Fosamprenavir Calcium & Sodium Alginate
Other: Placebo

First Posted Date: 2024-11-25

Last Posted Date: 2024-12-05

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 60

Registration Number: NCT06704100

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Palmitic Acid and Human Microvascular Function

Phase 2

Not yet recruiting

Conditions: Microvascular Dysfunction
Microvasculature
Cardiovascular Diseases
Cardiovascular Diseases (CVD)
Microvascular Health
Obesity and Overweight

Interventions: Dietary Supplement: Quercetin (dietary supplement)
Drug: Placebo

First Posted Date: 2024-11-12

Last Posted Date: 2025-04-30

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 40

Registration Number: NCT06683534

Locations: 🇺🇸
Froedtert Hospital, Wauwatosa, Wisconsin, United States

Defining Mechanisms of Surgical Site Infection After Oral Cancer Surgery

Recruiting

Conditions: Oral Cancer

First Posted Date: 2024-11-12

Last Posted Date: 2025-05-21

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 40

Registration Number: NCT06681935

Locations: 🇺🇸
Froedtert & the Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Exploring the Efficacy of Assistive Artificial Intelligence for Ultrasound Guided Regional Anesthesia in Residency Training

Conditions: Regional Anesthesia

First Posted Date: 2024-10-31

Last Posted Date: 2025-04-29

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 20

Registration Number: NCT06667401

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Understanding the Implementation of Cued Exercise Using Wearable Devices and a Custom Smartphone Application Following Bone Marrow Transplant.

Not Applicable

Active, not recruiting

Conditions: Blood Cancer
Bone Marrow Transplant (BMT)

First Posted Date: 2024-10-16

Last Posted Date: 2025-02-14

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 15

Registration Number: NCT06645132

Locations: 🇺🇸
Froedtert Hospital, Milwaukee, Wisconsin, United States

A Clinical Trial of the Administration of Light Therapy to Prevent and Treat Mouth Sores in Children With Cancer

Not Applicable

Not yet recruiting

Conditions: Mucositis Oral

Interventions: Device: Photobiomodulation

First Posted Date: 2024-10-02

Last Posted Date: 2025-04-30

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 50

Registration Number: NCT06623305

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications.

Early Phase 1

Recruiting

Conditions: Substance Use Disorder (SUD)

Interventions: Drug: Hydromorphone Patient Controlled Analgelsic
Drug: Regional Anesthesia
Procedure: Epidural local anesthetic infusion

First Posted Date: 2024-10-01

Last Posted Date: 2025-04-29

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 20

Registration Number: NCT06617949

Locations: 🇺🇸
Froedtert Hospital Milwaukee, Wisconsin 53226, Milwaukee, Wisconsin, United States
🇺🇸
Froedtert Hospital, Milwaukee, Wisconsin, United States

Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma

Phase 2

Not yet recruiting

Conditions: Diffuse Large B Cell Lymphoma (DLBCL)

Interventions: Drug: Polatuzumab Vedotin
Drug: Mosunetuzumab
Drug: Cyclophosphamide
Drug: Doxorubicin
Drug: Prednisone
Other: Pegfilgrastim

First Posted Date: 2024-09-19

Last Posted Date: 2025-02-18

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 31

Registration Number: NCT06594939

Locations: 🇺🇸
Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Improving In-hospital and Post-discharge Patient Education for Mild Traumatic Brain Injury

Not Applicable

Conditions: Concussion, Mild
Traumatic Brain Injury

Interventions: Other: Clinical implementation strategies

First Posted Date: 2024-09-16

Last Posted Date: 2024-09-19

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 5831

Registration Number: NCT06595914

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy